🇺🇸·1d agoResearch
NCT05789082: A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- July 13, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
Universitätsklinikum Erlangen/3h ago
Die Kunst des „Im Wandel-Seins“
AACR/3h ago
Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk
University of Edinburgh/4h ago
Swimmer Archie Goodburn goes from graduation to the Games
European Molecular Biology Laboratory (EMBL)/5h ago